Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 4L454 | — |
wrong age /dose of Kinrix was administered to a 4 month old baby; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number 4L454, expiry date 16-OCT-2026) for prophylaxis. Previously administered products included Dtap vaccine (received first dose in JUN-2025). Concomitant products included Diphtheria vaccine toxoid, Pertussis vaccine acellular, Tetanus vaccine toxoid (Dtap). On 05-AUG-2025, the patient received the 2nd dose of Kinrix. On 05-AUG-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: wrong age /dose of Kinrix was administered to a 4 month old baby). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 26-SEP-2025 and 27-SEP-2025 A nurse reported that a dose of Kinrix was administered to a 4 month old baby. The patient was supposed to get Infanrix and IPV separately. The patient has received a Dtap dose back on Jun 2025, so this Kinrix shot corresponded to 2nd Dtap in the primary series.
DTAP